The Effectiveness of an Exergame-based Intervention

Sponsor
University of Bern (Other)
Overall Status
Recruiting
CT.gov ID
NCT05712317
Collaborator
(none)
34
1
2
3.9
8.6

Study Details

Study Description

Brief Summary

This randomized control trial aims to compare the effects of a regular exergame-based intervention and a regular moderate-intensity endurance exercise in healthy individuals. The main questions it aims to answer are:

• Is regular exergame-based training an effective intervention to improve different health and performance parameters in healthy adults? Can the exergaming intervention improve health and performance parameters similar to a moderate-intensity endurance exercise intervention? Throughout the intervention period (8 weeks), participants will participate in regular training sessions (3x/week) in an exergame called the ExerCube.

Researchers will compare the effects to a control group who participates in regular (3x/week) moderate-intensity endurance exercise to see if the exergaming intervention induces similar effects on health and performance parameters.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exergame Intervention
  • Behavioral: Moderate-intensity endurance exercise
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
34 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Evaluation of the Effectiveness of Regular Training in the ExerCube - A Randomized Controlled Trial
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exergame Intervention

8-week exergame-based intervention consisting of 3 sessions per week lasting between 20-40 Minutes. The intervention will consist of playing the game Sphery racer in the exergame called ExerCube.

Behavioral: Exergame Intervention
8-week exergame-based intervention 3x per week

Active Comparator: Moderate-intensity endurance exercise

8-week moderate-intensity endurance exercise consisting of 3 sessions per week lasting between 20-40 minutes. The intervention will consist of a running exercise on a treadmill or riding on a bicycle ergometer.

Behavioral: Moderate-intensity endurance exercise
8-week moderate-intensity endurance exercise 3x per week

Outcome Measures

Primary Outcome Measures

  1. Changes from baseline in maximum oxygen consumption at week 8 [Baseline and week 8]

    Maximum oxygen consumption will be obtained during a cardiopulmonary exercise test on a bicycle ergometer using a validated metabolic cart.

Secondary Outcome Measures

  1. Changes from baseline in blood pressure at week 8 [Baseline and week 8]

    Blood pressure will be obtained non-invasively using a clinically validated device for hemodynamic measurements. After a 10 min supine rest, a minimum of two readings will be performed on the right upper arm using customized arm cuffs.

  2. Changes from baseline in pulse wave velocity at week 8 [Baseline and week 8]

    Pulse wave velocity will be obtained non-invasively using a clinically validated device for hemodynamic measurements. After a 10 min supine rest, a minimum of two readings will be performed on the right upper arm using customized arm cuffs.

Other Outcome Measures

  1. Changes from baseline in body mass index at week 8 [Baseline and week 8]

    Height will be measured barefoot with a stadiometer to the nearest 0.5 cm. Body mass will be measured using a scale. Body mass index will be calculated as a function of weight in kilogram and height in meters.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy female and male adults

  • Aged 18-60 years

  • Free from acute and chronic diseases

  • Free from movement restrictions or injuries to the musculoskeletal system

  • Provided written informed consent

Exclusion Criteria:
  • Underlying health condition that could compromise the safety of the physical exercise

  • Were taking cardiovascular medications

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Bern Bern Switzerland 3012

Sponsors and Collaborators

  • University of Bern

Investigators

  • Principal Investigator: Sascha Ketelhut, Dr., University of Bern

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Bern
ClinicalTrials.gov Identifier:
NCT05712317
Other Study ID Numbers:
  • 2021-03-00006
First Posted:
Feb 3, 2023
Last Update Posted:
Feb 3, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Bern

Study Results

No Results Posted as of Feb 3, 2023